Functions and modulation of PKM2 activity by human papillomavirus E7 oncoprotein (Review)
- Authors:
- Chengzhi Gui
- Mingyu Ji
- Yiying Song
- Jing Wang
- Yunying Zhou
-
Affiliations: Department of Clinical Laboratory Diagnosis, Shandong First Medical University, Jinan, Shandong 250012, P.R. China, Medical Research and Laboratory Diagnostic Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250013, P.R. China, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, P.R. China - Published online on: November 14, 2022 https://doi.org/10.3892/ol.2022.13593
- Article Number: 7
-
Copyright: © Gui et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Warburg O and Minami S: Versuche an überlebendem carcinom-gewebe. Klin Wochenschr. 2:776–777. 1923. View Article : Google Scholar | |
|
Warburg O: Über den stoffwechsel der carcinomzelle. Naturwissenschaften. 12:1131–1137. 1924. View Article : Google Scholar | |
|
Hoppe-Seyler K, Bossler F, Braun JA, Herrmann AL and Hoppe-Seyler F: The HPV E6/E7 oncogenes: Key factors for viral carcinogenesis and therapeutic targets. Trends Microbiol. 26:158–168. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Hitosugi T, Kang S, Vander Heiden MG, Chung TW, Elf S, Lythgoe K, Dong S, Lonial S, Wang X, Chen GZ, et al: Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci Signal. 2:ra732009. View Article : Google Scholar : PubMed/NCBI | |
|
Zahra K, Dey T, Ashish, Mishra SP and Pandey U: Pyruvate kinase M2 and cancer: The role of PKM2 in promoting tumorigenesis. Front Oncol. 10:1592020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Z: PKM2, function and expression and regulation. Cell Biosci. 9:522019. View Article : Google Scholar : PubMed/NCBI | |
|
Malla R and Kamal MA: E6 and E7 oncoproteins: Potential targets of cervical cancer. Curr Med Chem. 28:8163–8181. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Lü S, Deng J, Liu H, Liu B, Yang J, Miao Y, Li J, Wang N, Jiang C, Xu Q, et al: PKM2-dependent metabolic reprogramming in CD4+ T cells is crucial for hyperhomocysteinemia-accelerated atherosclerosis. J Mol Med (Berl). 96:585–600. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Mazurek S, Boschek CB, Hugo F and Eigenbrodt E: Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol. 15:300–308. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Nandi S, Razzaghi M, Srivastava D and Dey M: Structural basis for allosteric regulation of pyruvate kinase M2 by phosphorylation and acetylation. J Biol Chem. 295:17425–17440. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Miyake-Stoner SJ and O'Shea CC: Metabolism goes viral. Cell Metab. 19:549–550. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Pant A, Dsouza L and Yang Z: Alteration in cellular signaling and metabolic reprogramming during viral infection. mBio. 12:e00635212021. View Article : Google Scholar : PubMed/NCBI | |
|
Thaker SK, Ch'ng J and Christofk HR: Viral hijacking of cellular metabolism. BMC Biol. 17:592019. View Article : Google Scholar : PubMed/NCBI | |
|
Kori M and Arga KY: Pathways involved in viral oncogenesis: New perspectives from virus-host protein interactomics. Biochim Biophys Acta Mol Basis Dis. 1866:1658852020. View Article : Google Scholar : PubMed/NCBI | |
|
French D, Belleudi F, Mauro MV, Mazzetta F, Raffa S, Fabiano V, Frega A and Torrisi MR: Expression of HPV16 E5 down-modulates the TGFbeta signaling pathway. Mol Cancer. 12:382013. View Article : Google Scholar : PubMed/NCBI | |
|
Martínez-Ramírez I, Carrillo-García A, Contreras-Paredes A, Ortiz-Sánchez E, Cruz-Gregorio A and Lizano M: Regulation of cellular metabolism by high-risk human papillomaviruses. Int J Mol Sci. 19:18392018. View Article : Google Scholar : PubMed/NCBI | |
|
Kim H, Jang H, Kim TW, Kang BH, Lee SE, Jeon YK, Chung DH, Choi J, Shin J, Cho EJ and Youn HD: Core pluripotency factors directly regulate metabolism in embryonic stem cell to maintain pluripotency. Stem Cells. 33:2699–2711. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Hou PP, Luo LJ, Chen HZ, Chen QT, Bian XL, Wu SF, Zhou JX, Zhao WX, Liu JM, Wang XM, et al: Ectosomal PKM2 promotes HCC by inducing macrophage differentiation and remodeling the tumor microenvironment. Mol Cell. 78:1192–1206.e10. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Mazurek S, Zwerschke W, Jansen-Dürr P and Eigenbrodt E: Metabolic cooperation between different oncogenes during cell transformation: Interaction between activated ras and HPV-16 E7. Oncogene. 20:6891–6898. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Mazurek S, Zwerschke W, Jansen-Dürr P and Eigenbrodt E: Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: Role of pyruvate kinase type M2 and the glycolytic-enzyme complex. Biochem J. 356:247–256. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Lee SA, Ho C, Troxler M, Lin CY and Chung SH: Non-metabolic functions of PKM2 contribute to cervical cancer cell proliferation induced by the HPV16 E7 oncoprotein. Viruses. 13:4332021. View Article : Google Scholar : PubMed/NCBI | |
|
Abudula A, Rouzi N, Xu L, Yang Y and Hasimu A: Tissue-based metabolomics reveals potential biomarkers for cervical carcinoma and HPV infection. Bosn J Basic Med Sci. 20:78–87. 2020.PubMed/NCBI | |
|
Wang R, Pan W, Jin L, Huang W, Li Y, Wu D, Gao C, Ma D and Liao S: Human papillomavirus vaccine against cervical cancer: Opportunity and challenge. Cancer Lett. 471:88–102. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR and Stanley MA: The biology and life-cycle of human papillomaviruses. Vaccine. 30 (Suppl 5):F55–F70. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
No authors listed. Human papillomavirus vaccines: WHO position paper, May 2017. Wkly Epidemiol Rec. 92:241–268. 2017.(In English, French). PubMed/NCBI | |
|
Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A and zur Hausen H: Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 314:111–114. 1985. View Article : Google Scholar : PubMed/NCBI | |
|
Münger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M and Zacny VL: Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene. 20:7888–7898. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Scarth JA, Patterson MR, Morgan EL and Macdonald A: The human papillomavirus oncoproteins: A review of the host pathways targeted on the road to transformation. J Gen Virol. 102:0015402021. View Article : Google Scholar : PubMed/NCBI | |
|
Zwerschke W, Mazurek S, Massimi P, Banks L, Eigenbrodt E and Jansen-Dürr P: Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein. Proc Natl Acad Sci USA. 96:1291–1296. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Israelsen WJ, Dayton TL, Davidson SM, Fiske BP, Hosios AM, Bellinger G, Li J, Yu Y, Sasaki M, Horner JW, et al: PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. Cell. 155:397–409. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Takenaka M, Noguchi T, Sadahiro S, Hirai H, Yamada K, Matsuda T, Imai E and Tanaka T: Isolation and characterization of the human pyruvate kinase M gene. Eur J Biochem. 198:101–106. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Mazurek S: Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells. Int J Biochem Cell Biol. 43:969–980. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Alquraishi M, Puckett DL, Alani DS, Humidat AS, Frankel VD, Donohoe DR, Whelan J and Bettaieb A: Pyruvate kinase M2: A simple molecule with complex functions. Free Radic Biol Med. 143:176–192. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Dombrauckas JD, Santarsiero BD and Mesecar AD: Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. Biochemistry. 44:9417–9429. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Wang P, Sun C, Zhu T and Xu Y: Structural insight into mechanisms for dynamic regulation of PKM2. Protein Cell. 6:275–287. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Otto AM: Warburg effect(s)-a biographical sketch of Otto Warburg and his impacts on tumor metabolism. Cancer Metab. 4:52016. View Article : Google Scholar : PubMed/NCBI | |
|
Yang W and Lu Z: Nuclear PKM2 regulates the Warburg effect. Cell Cycle. 12:3154–3158. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang R, Shen M, Wu C, Chen Y, Lu J, Li J, Zhao L, Meng H, Zhou X, Huang G, et al: HDAC8-dependent deacetylation of PKM2 directs nuclear localization and glycolysis to promote proliferation in hepatocellular carcinoma. Cell Death Dis. 11:10362020. View Article : Google Scholar : PubMed/NCBI | |
|
Hua Q, Mi B, Xu F, Wen J, Zhao L, Liu J and Huang G: Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis. Theranostics. 10:4762–4778. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Onodera Y, Nam JM and Bissell MJ: Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathways. J Clin Invest. 124:367–384. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lv L, Xu YP, Zhao D, Li FL, Wang W, Sasaki N, Jiang Y, Zhou X, Li TT, Guan KL, et al: Mitogenic and oncogenic stimulation of K433 acetylation promotes PKM2 protein kinase activity and nuclear localization. Mol Cell. 52:340–352. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Tirpe AA, Gulei D, Ciortea SM, Crivii C and Berindan-Neagoe I: Hypoxia: Overview on hypoxia-mediated mechanisms with a focus on the role of HIF genes. Int J Mol Sci. 20:61402019. View Article : Google Scholar : PubMed/NCBI | |
|
Magaway C, Kim E and Jacinto E: Targeting mTOR and metabolism in cancer: Lessons and innovations. Cells. 8:15842019. View Article : Google Scholar : PubMed/NCBI | |
|
Reyes-González JM and Vivas-Mejía PE: c-MYC and epithelial ovarian cancer. Front Oncol. 11:6015122021. View Article : Google Scholar : PubMed/NCBI | |
|
Azoitei N, Becher A, Steinestel K, Rouhi A, Diepold K, Genze F, Simmet T and Seufferlein T: PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation. Mol Cancer. 15:32016. View Article : Google Scholar : PubMed/NCBI | |
|
Feng J, Dai W, Mao Y, Wu L, Li J, Chen K, Yu Q, Kong R, Li S, Zhang J, et al: Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis. J Exp Clin Cancer Res. 39:242020. View Article : Google Scholar : PubMed/NCBI | |
|
Noguchi T, Yamada K, Inoue H, Matsuda T and Tanaka T: The L- and R-type isozymes of rat pyruvate kinase are produced from a single gene by use of different promoters. J Biol Chem. 262:14366–14371. 1987. View Article : Google Scholar : PubMed/NCBI | |
|
Schäfer D, Hamm-Künzelmann B and Brand K: Glucose regulates the promoter activity of aldolase A and pyruvate kinase M2 via dephosphorylation of Sp1. FEBS Lett. 417:325–328. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Tang JY, Li DY, He L, Qiu XS, Wang EH and Wu GP: HPV 16 E6/E7 promote the glucose uptake of GLUT1 in lung cancer through downregulation of TXNIP due to inhibition of PTEN phosphorylation. Front Oncol. 10:5595432020. View Article : Google Scholar : PubMed/NCBI | |
|
Netzker R, Weigert C and Brand K: Role of the stimulatory proteins Sp1 and Sp3 in the regulation of transcription of the rat pyruvate kinase M gene. Eur J Biochem. 245:174–181. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Yang JH, Wu MZ, Wang XB, Wang S, Qiu XS, Wang EH and Wu GP: HPV16 E6/E7 upregulate hTERC mRNA and gene amplification levels by relieving the effect of LKB1 on Sp1 phosphorylation in lung cancer cells. Ther Adv Med Oncol. 12:17588359209175622020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu H, Wu J, Zhang W, Luo H, Shen Z, Cheng H and Zhu X: PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer. Sci Rep. 6:307882016. View Article : Google Scholar : PubMed/NCBI | |
|
Bodily JM, Mehta KP and Laimins LA: Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases. Cancer Res. 71:1187–1195. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Gu J, Li X, Zhao L, Yang Y, Xue C, Gao Y, Li J, Han Q, Sun Z, Bai C and Zhao RC: The role of PKM2 nuclear translocation in the constant activation of the NF-κB signaling pathway in cancer-associated fibroblasts. Cell Death Dis. 12:2912021. View Article : Google Scholar : PubMed/NCBI | |
|
Wang N, Zhan T, Ke T, Huang X, Ke D, Wang Q and Li H: Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancer. Br J Cancer. 110:1034–1044. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
David CJ, Chen M, Assanah M, Canoll P and Manley JL: HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature. 463:364–368. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Luo W, Hu H, Chang R, Zhong J, Knabel M, O'Meally R, Cole RN, Pandey A and Semenza GL: Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell. 145:732–744. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Horn D, Hess J, Freier K, Hoffmann J and Freudlsperger C: Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma. Expert Opin Ther Targets. 19:795–805. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Freudlsperger C, Burnett JR, Friedman JA, Kannabiran VR, Chen Z and Van Waes C: EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: Attractive targets for molecular-oriented therapy. Expert Opin Ther Targets. 15:63–74. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Chiou TT, Chau YY, Chen JB, Hsu HH, Hung SP and Lee WC: Rapamycin attenuates PLA2R activation-mediated podocyte apoptosis via the PI3K/AKT/mTOR pathway. Biomed Pharmacother. 144:1123492021. View Article : Google Scholar : PubMed/NCBI | |
|
Bossler F, Hoppe-Seyler K and Hoppe-Seyler F: PI3K/AKT/mTOR signaling regulates the virus/host cell crosstalk in HPV-positive cervical cancer cells. Int J Mol Sci. 20:21882019. View Article : Google Scholar : PubMed/NCBI | |
|
Strickland SW and Vande Pol S: The human papillomavirus 16 E7 oncoprotein attenuates AKT signaling to promote internal ribosome entry site-dependent translation and expression of c-MYC. J Virol. 90:5611–5621. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Bossler F, Kuhn BJ, Günther T, Kraemer SJ, Khalkar P, Adrian S, Lohrey C, Holzer A, Shimobayashi M, Dürst M, et al: Repression of human papillomavirus oncogene expression under hypoxia is mediated by PI3K/mTORC2/AKT signaling. mBio. 10:e02323–18. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Wang M, Qiao X, Cooper T, Pan W, Liu L, Hayball J, Lin J, Cui X, Zhou Y, Zhang S, et al: HPV E7-mediated NCAPH ectopic expression regulates the carcinogenesis of cervical carcinoma via PI3K/AKT/SGK pathway. Cell Death Dis. 11:10492020. View Article : Google Scholar : PubMed/NCBI | |
|
Menges CW, Baglia LA, Lapoint R and McCance DJ: Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein. Cancer Res. 66:5555–5559. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Yang W, Xia Y, Cao Y, Zheng Y, Bu W, Zhang L, You MJ, Koh MY, Cote G, Aldape K, et al: EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis. Mol Cell. 48:771–784. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Hu G, Liu W, Mendelsohn J, Ellis LM, Radinsky R, Andreeff M and Deisseroth AB: Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells. J Natl Cancer Inst. 89:1271–1276. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Hoesel B and Schmid JA: The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 12:862013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Q, Lenardo MJ and Baltimore D: 30 Years of NF-κB: A blossoming of relevance to human pathobiology. Cell. 168:37–57. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Havard L, Delvenne P, Fraré P, Boniver J and Giannini SL: Differential production of cytokines and activation of NF-kappaB in HPV-transformed keratinocytes. Virology. 298:271–285. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Senba M and Mori N: Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection. Oncol Rev. 6:e172012. View Article : Google Scholar : PubMed/NCBI | |
|
Senba M, Buziba N, Mori N, Fujita S, Morimoto K, Wada A and Toriyama K: Human papillomavirus infection induces NF-κB activation in cervical cancer: A comparison with penile cancer. Oncol Lett. 2:65–68. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Tontonoz P and Spiegelman BM: Fat and beyond: The diverse biology of PPARgamma. Annu Rev Biochem. 77:289–312. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Panasyuk G, Espeillac C, Chauvin C, Pradelli LA, Horie Y, Suzuki A, Annicotte JS, Fajas L, Foretz M, Verdeguer F, et al: PPARγ contributes to PKM2 and HK2 expression in fatty liver. Nat Commun. 3:6722012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang S, Liu F, Mao X, Huang J, Yang J, Yin X, Wu L, Zheng L and Wang Q: Elevation of miR-27b by HPV16 E7 inhibits PPARγ expression and promotes proliferation and invasion in cervical carcinoma cells. Int J Oncol. 47:1759–1766. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Chen M, Zhang J and Manley JL: Turning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA. Cancer Res. 70:8977–8980. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Rampias T, Boutati E, Pectasides E, Sasaki C, Kountourakis P, Weinberger P and Psyrri A: Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells. Mol Cancer Res. 8:433–443. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Hu Z, Müller S, Qian G, Xu J, Kim S, Chen Z, Jiang N, Wang D, Zhang H, Saba NF, et al: Human papillomavirus 16 oncoprotein regulates the translocation of β-catenin via the activation of epidermal growth factor receptor. Cancer. 121:214–225. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Wang YW, Chang HS, Lin CH and Yu WC: HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity. Int J Biochem Cell Biol. 39:402–412. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Lu Z and Hunter T: Degradation of activated protein kinases by ubiquitination. Annu Rev Biochem. 78:435–475. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Christofk HR, Vander Heiden MG, Wu N, Asara JM and Cantley LC: Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature. 452:181–186. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou Z, Li M, Zhang L, Zhao H, Şahin Ö, Chen J, Zhao JJ, Songyang Z and Yu D: Oncogenic kinase-induced PKM2 tyrosine 105 phosphorylation converts nononcogenic PKM2 to a tumor promoter and induces cancer stem-like cells. Cancer Res. 78:2248–2261. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Lin Y, Zhai H, Ouyang Y, Lu Z, Chu C, He Q and Cao X: Knockdown of PKM2 enhances radiosensitivity of cervical cancer cells. Cancer Cell Int. 19:1292019. View Article : Google Scholar : PubMed/NCBI | |
|
Wang C, Li Y, Yan S, Wang H, Shao X, Xiao M, Yang B, Qin G, Kong R, Chen R and Zhang N: Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2. Nat Commun. 11:31622020. View Article : Google Scholar : PubMed/NCBI | |
|
Yang W, Zheng Y, Xia Y, Ji H, Chen X, Guo F, Lyssiotis CA, Aldape K, Cantley LC and Lu Z: ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat Cell Biol. 14:1295–1304. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Wellen KE and Thompson CB: Cellular metabolic stress: Considering how cells respond to nutrient excess. Mol Cell. 40:323–332. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Anastasiou D, Poulogiannis G, Asara JM, Boxer MB, Jiang JK, Shen M, Bellinger G, Sasaki AT, Locasale JW, Auld DS, et al: Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science. 334:1278–1283. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Guo JZ, Liu Y, Wang K, Ding W, Wang H, Liu X, Zhou S, Lu XC, Yang HB, et al: Nuclear lactate dehydrogenase A senses ROS to produce α-hydroxybutyrate for HPV-induced cervical tumor growth. Nat Commun. 9:44292018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Liu J, Jin X, Zhang D, Li D, Hao F, Feng Y, Gu S, Meng F, Tian M, et al: O-GlcNAcylation destabilizes the active tetrameric PKM2 to promote the Warburg effect. Proc Natl Acad Sci USA. 114:13732–13737. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zeng Q, Zhao RX, Chen J, Li Y, Li XD, Liu XL, Zhang WM, Quan CS, Wang YS, Zhai YX, et al: O-linked GlcNAcylation elevated by HPV E6 mediates viral oncogenesis. Proc Natl Acad Sci USA. 113:9333–9338. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Li L, Peng G, Liu X, Zhang Y, Han H and Liu ZR: Pyruvate kinase M2 coordinates metabolism switch between glycolysis and glutaminolysis in cancer cells. iScience. 23:1016842020. View Article : Google Scholar : PubMed/NCBI | |
|
Reinstein E, Scheffner M, Oren M, Ciechanover A and Schwartz A: Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: Targeting via ubiquitination of the N-terminal residue. Oncogene. 19:5944–5950. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Alani RM and Münger K: Human papillomaviruses and associated malignancies. J Clin Oncol. 16:330–337. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Yang W, Xia Y, Ji H, Zheng Y, Liang J, Huang W, Gao X, Aldape K and Lu Z: Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation. Nature. 480:118–122. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Gao X, Wang H, Yang JJ, Liu X and Liu ZR: Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol Cell. 45:598–609. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Yue G, Tang J, Zhang L, Niu H, Li H and Luo S: CD276 suppresses CAR-T cell function by promoting tumor cell glycolysis in esophageal squamous cell carcinoma. J Gastrointest Oncol. 12:38–51. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Xiao M, Xie J, Wu Y, Wang G, Qi X, Liu Z, Wang Y, Wang X, Hoque A, Oakhill J, et al: The eEF2 kinase-induced STAT3 inactivation inhibits lung cancer cell proliferation by phosphorylation of PKM2. Cell Commun Signal. 18:252020. View Article : Google Scholar : PubMed/NCBI | |
|
Shukla S, Mahata S, Shishodia G, Pandey A, Tyagi A, Vishnoi K, Basir SF, Das BC and Bharti AC: Functional regulatory role of STAT3 in HPV16-mediated cervical carcinogenesis. PLoS One. 8:e678492013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang W, Wu X, Hu L, Ma Y, Xiu Z, Huang B, Feng Y and Tang X: Overexpression of human papillomavirus type 16 oncoproteins enhances epithelial-mesenchymal transition via STAT3 signaling pathway in non-small cell lung cancer cells. Oncol Res. 25:843–852. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Morgan EL and Macdonald A: Manipulation of JAK/STAT signalling by high-risk HPVs: Potential therapeutic targets for HPV-associated malignancies. Viruses. 12:9772020. View Article : Google Scholar : PubMed/NCBI | |
|
Christensen DR, Calder PC and Houghton FD: GLUT3 and PKM2 regulate OCT4 expression and support the hypoxic culture of human embryonic stem cells. Sci Rep. 5:175002015. View Article : Google Scholar : PubMed/NCBI | |
|
Lee J, Kim HK, Han YM and Kim J: Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription. Int J Biochem Cell Biol. 40:1043–1054. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Brehm A, Ohbo K, Zwerschke W, Botquin V, Jansen-Dürr P and Schöler HR: Synergism with germ line transcription factor Oct-4: Viral oncoproteins share the ability to mimic a stem cell-specific activity. Mol Cell Biol. 19:2635–2643. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Park EG, Pyo SJ, Cui Y, Yoon SH and Nam JW: Tumor immune microenvironment lncRNAs. Brief Bioinform. 23:bbab5042022. View Article : Google Scholar : PubMed/NCBI | |
|
Hinshaw DC and Shevde LA: The tumor microenvironment innately modulates cancer progression. Cancer Res. 79:4557–4566. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Adem S, Comakli V and Uzun N: Pyruvate kinase activators as a therapy target: A patent review 2011–2017. Expert Opin Ther Pat. 28:61–68. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang T, Marquardt C and Foker J: Aerobic glycolysis during lymphocyte proliferation. Nature. 261:702–705. 1976. View Article : Google Scholar : PubMed/NCBI | |
|
Wang R, Dillon CP, Shi LZ, Milasta S, Carter R, Finkelstein D, McCormick LL, Fitzgerald P, Chi H, Munger J and Green DR: The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity. 35:871–882. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Boxer MB, Jiang JK, Vander Heiden MG, Shen M, Skoumbourdis AP, Southall N, Veith H, Leister W, Austin CP, Park HW, et al: Evaluation of substituted N,N'-diarylsulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase. J Med Chem. 53:1048–1055. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang JK, Boxer MB, Vander Heiden MG, Shen M, Skoumbourdis AP, Southall N, Veith H, Leister W, Austin CP, Park HW, et al: Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase. Bioorg Med Chem Lett. 20:3387–3393. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Angiari S, Runtsch MC, Sutton CE, Palsson-McDermott EM, Kelly B, Rana N, Kane H, Papadopoulou G, Pearce EL, Mills KHG and O'Neill LAJ: Pharmacological activation of pyruvate kinase M2 inhibits CD4+ T cell pathogenicity and suppresses autoimmunity. Cell Metab. 31:391–405.e8. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Damasceno LEA, Prado DS, Veras FP, Fonseca MM, Toller-Kawahisa JE, Rosa MH, Públio GA, Martins TV, Ramalho FS, Waisman A, et al: PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation. J Exp Med. 217:e201906132020. View Article : Google Scholar : PubMed/NCBI | |
|
Deng J, Lü S, Liu H, Liu B, Jiang C, Xu Q, Feng J and Wang X: Homocysteine activates B cells via regulating PKM2-dependent metabolic reprogramming. J Immunol. 198:170–183. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Yang L, Xie M, Yang M, Yu Y, Zhu S, Hou W, Kang R, Lotze MT, Billiar TR, Wang H, et al: PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis. Nat Commun. 5:44362014. View Article : Google Scholar : PubMed/NCBI | |
|
Shirai T, Nazarewicz RR, Wallis BB, Yanes RE, Watanabe R, Hilhorst M, Tian L, Harrison DG, Giacomini JC, Assimes TL, et al: The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease. J Exp Med. 213:337–354. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Palsson-McDermott EM, Curtis AM, Goel G, Lauterbach MAR, Sheedy FJ, Gleeson LE, van den Bosch MWM, Quinn SR, Domingo-Fernandez R, Johnston DGW, et al: Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages. Cell Metab. 21:3472015. View Article : Google Scholar : PubMed/NCBI | |
|
Wang L, Deng Z, Sun Y, Zhao Y, Li Y, Yang M, Yuan R, Liu Y, Qian Z, Zhou F and Kang H: The study on the regulation of Th cells by mesenchymal stem cells through the JAK-STAT signaling pathway to protect naturally aged sepsis model rats. Front Immunol. 13:8206852022. View Article : Google Scholar : PubMed/NCBI | |
|
Lochmatter C, Fischer R, Charles PD, Yu Z, Powrie F and Kessler BM: Integrative phosphoproteomics links IL-23R signaling with metabolic adaptation in lymphocytes. Sci Rep. 6:244912016. View Article : Google Scholar : PubMed/NCBI | |
|
Deng W, Zhu S, Zeng L, Liu J, Kang R, Yang M, Cao L, Wang H, Billiar TR, Jiang J, et al: The circadian clock controls immune checkpoint pathway in sepsis. Cell Rep. 24:366–378. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Park YS, Kim DJ, Koo H, Jang SH, You YM, Cho JH, Yang SJ, Yu ES, Jung Y, Lee DC, et al: AKT-induced PKM2 phosphorylation signals for IGF-1-stimulated cancer cell growth. Oncotarget. 7:48155–48167. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Long L, Zhao C, Ozarina M, Zhao X, Yang J and Chen H: Targeting immune checkpoints in lung cancer: Current landscape and future prospects. Clin Drug Investig. 39:341–353. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Palsson-McDermott EM, Dyck L, Zasłona Z, Menon D, McGettrick AF, Mills KHG and O'Neill LA: Pyruvate kinase M2 is required for the expression of the immune checkpoint PD-L1 in immune cells and tumors. Front Immunol. 8:13002017. View Article : Google Scholar : PubMed/NCBI |
